Vir Biotechnology's market cap is currently $1.35B. The company's EPS TTM is $-3.923; its P/E ratio is ―; Vir Biotechnology is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-0.87. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 86.18M	$ 1.58B	$ 1.09B	$ 67.25M	$ 711.00K
Gross Profit	$ 83.42M	$ 1.43B	$ 1.02B	$ -234.33M	$ -147.76M
Operating Income	$ -684.30M	$ 833.07M	$ 276.89M	$ -296.98M	$ -177.98M
EBITDA	$ -664.85M	$ 833.07M	$ 420.75M	$ -289.80M	$ -173.46M
Net Income	$ -615.06M	$ 515.84M	$ 528.58M	$ -298.67M	$ -174.68M
Balance Sheet
Cash & Short-Term Investments	$ 1.52B	$ 2.40B	$ 708.14M	$ 736.86M	$ 383.44M
Total Assets	$ 1.92B	$ 2.80B	$ 1.95B	$ 918.76M	$ 512.07M
Total Debt	$ 124.54M	$ 127.97M	$ 133.56M	$ 66.56M	$ 237.00K
Net Debt	$ -117.04M	$ -720.66M	$ -214.25M	$ -370.02M	$ -109.10M
Total Liabilities	$ 328.82M	$ 724.13M	$ 522.42M	$ 201.91M	$ 88.13M
Stockholders' Equity	$ 1.59B	$ 2.08B	$ 1.43B	$ 716.85M	$ 423.94M
Cash Flow
Free Cash Flow	$ -800.36M	$ 1.60B	$ -69.41M	$ -197.49M	$ -138.57M
Operating Cash Flow	$ -778.78M	$ 1.66B	$ -47.59M	$ -190.94M	$ -129.63M
Investing Cash Flow	$ 164.63M	$ -1.19B	$ -140.81M	$ -9.86M	$ -256.16M
Financing Cash Flow	$ 7.48M	$ 34.76M	$ 100.33M	$ 529.47M	$ 449.24M

Currency in USD

Vir Biotechnology Earnings and Revenue History

Income Statement >

Vir Biotechnology Debt to Assets

Balance Sheet >

Vir Biotechnology Cash Flow

Cash Flow >

Vir Biotechnology Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing